Data for ST003245   

(Analysis AN005315): Average values per metabolite and experimental factor (Units:relative intensities)

Metabolite structureAll dataF1F2F3
LPC 14:0
0.02 0.01 0.01
LPC 16:0
0.44 0.37 0.21
LPC 16:1
0.04 0.01 0.04
LPC 18:0
0.85 0.91 0.11
LPC 18:1
0.31 0.19 0.13
LPC 18:2
0.02 0.01 0.01
LPC 20:3
0.01 0.01 0.00
LPC 20:4
0.01 0.00 0.00
LPC 20:5
0.00 0.00 0.00
LPC 22:5
0.00 0.00 0.00
LPC 22:6
0.00 0.00 0.00
LPE 14:0
0.32 0.44 0.39
LPE 16:0
0.46 0.66 0.63
LPE 16:1
0.19 0.15 0.18
LPE 18:0
0.01 0.01 0.01
LPE 18:1
0.00 0.00 0.00
LPE 18:2
0.01 0.01 0.01
LPE 20:3
0.01 0.01 0.00
LPE 20:4
0.02 0.03 0.01
LPE 20:5
0.00 0.00 0.00
LPE 22:5
0.01 0.02 0.00
LPE 22:6
0.00 0.00 0.00
PC 14:0/14:0
0.54 - 0.64
PC 14:0_16:0
2.32 2.54 4.85
PC 14:0_16:1
0.60 0.34 1.84
PC 14:0_18:1
2.09 1.38 2.57
PC 14:0_18:2
0.09 0.07 0.11
PC 16:0/16:0
2.61 3.52 4.25
PC 16:0_16:1
9.07 7.79 16.23
PC 16:0_18:1
17.94 18.22 22.45
PC 16:0_18:2
1.51 1.98 1.85
PC 16:0_20:3
0.61 0.91 0.42
PC 16:0_20:4
0.80 1.39 0.54
PC 16:0_22:2
0.13 0.13 0.14
PC 16:0_22:4
0.16 0.23 0.06
PC 16:0_22:5
0.39 0.73 0.25
PC 16:0_22:6
0.28 0.51 0.18
PC 16:1/16:1
0.49 0.39 2.05
PC 16:1_18:0
2.59 2.06 1.00
PC 16:1_18:1
3.17 3.02 11.91
PC 16:1_20:3
0.06 0.09 0.12
PC 16:1_20:4
0.06 0.10 0.13
PC 16:1_22:1
0.12 0.09 0.24
PC 16:1_22:4
0.02 0.03 0.02
PC 16:1_22:5
0.05 0.07 0.07
PC 18:0_18:1
28.26 25.55 6.25
PC 18:0_18:2
1.71 2.46 0.47
PC 18:0_20:2
0.83 0.91 0.15
PC 18:0_20:3
1.79 2.42 0.36
PC 18:0_20:4
1.25 2.10 0.28
PC 18:0_22:4
0.47 0.63 0.06
PC 18:0_22:5
0.50 0.78 0.09
PC 18:0_22:6
0.32 0.65 0.06
PC 18:1/18:1
11.04 9.25 12.29
PC 18:1_18:2
1.17 1.70 1.76
PC 18:1_20:1
3.50 2.81 4.80
PC 18:1_20:3
0.58 0.88 0.41
PC 18:1_20:4
0.66 1.20 0.50
PC 18:1_20:5
0.09 0.23 0.09
PC 18:1_22:4
0.16 0.21 0.07
PC 18:1_22:5
0.33 0.56 0.19
PC 18:1_22:6
0.31 0.52 0.17
PC 18:2_22:5
0.02 0.04 0.01
PE 14:0/14:0
0.01 - 0.01
PE 14:0_16:0
0.04 0.03 0.18
PE 14:0_18:1
0.17 0.09 0.38
PE 16:0/16:0
0.07 0.06 0.21
PE 16:0_16:1
0.72 0.52 4.08
PE 16:0_18:0
0.48 0.72 0.48
PE 16:0_18:1
3.90 3.15 9.10
PE 16:0_18:2
0.24 0.29 0.65
PE 16:0_20:3
0.16 0.22 0.24
PE 16:0_20:4
0.58 0.93 1.17
PE 16:0_22:2
0.02 0.02 0.03
PE 16:0_22:4
0.07 0.07 0.07
PE 16:0_22:5
0.18 0.23 0.31
PE 16:0_22:6
0.20 0.24 0.48
PE 16:1_18:0
0.02 0.03 0.07
PE 16:1_18:1
0.12 0.08 0.10
PE 16:1_20:3
1.19 1.20 9.18
PE 16:1_20:4
0.03 0.05 0.10
PE 16:1_22:1
0.04 0.06 0.28
PE 16:1_22:4
0.14 0.13 0.52
PE 16:1_22:5
0.01 0.01 0.03
PE 18:0/18:0
0.01 0.01 0.03
PE 18:0_18:1
2.73 2.43 4.35
PE 18:0_18:2
0.09 0.17 0.04
PE 18:0_20:2
39.48 36.02 21.71
PE 18:0_20:3
2.56 3.15 1.92
PE 18:0_20:4
1.34 1.13 0.36
PE 18:0_22:4
6.38 7.45 2.62
PE 18:0_22:5
10.67 13.43 8.27
PE 18:0_22:6
3.23 3.23 0.53
PE 18:1/18:1
2.91 3.03 0.81
PE 18:1_18:2
2.30 2.70 0.96
PE 18:1_20:1
1.02 0.85 0.26
PE 18:1_20:3
12.72 10.48 20.42
PE 18:1_20:4
0.75 1.07 1.74
PE 18:1_20:5
2.09 1.64 3.70
PE 18:1_22:4
0.70 0.92 0.70
PE 18:1_22:5
1.39 2.67 2.40
PE 18:1_22:6
0.15 0.30 0.39
PE 18:2_22:5
0.38 0.39 0.23
PI 14:0_16:0
0.08 0.01 0.13
PI 14:0_18:1
0.21 0.06 0.54
PI 16:0/16:0
0.32 0.17 0.64
PI 16:0_16:1
0.32 0.14 5.04
PI 16:0_18:1
3.32 2.16 15.06
PI 16:0_18:2
0.16 0.13 0.61
PI 16:0_20:3
0.49 0.46 1.00
PI 16:0_20:4
0.66 0.67 2.41
PI 16:0_22:2
0.01 0.01 0.10
PI 16:0_22:4
0.11 0.12 0.21
PI 16:0_22:5
0.19 0.27 0.50
PI 16:0_22:6
0.11 0.12 0.40
PI 16:1_18:0
1.69 0.93 5.24
PI 16:1_18:1
0.76 0.51 9.98
PI 16:1_20:3
0.03 0.02 0.10
PI 16:1_20:4
0.03 0.02 0.16
PI 16:1_22:1
0.01 - 0.01
PI 16:1_22:4
0.00 0.00 0.01
PI 16:1_22:5
0.01 0.01 0.02
PI 18:0_18:1
23.54 15.76 15.30
PI 18:0_18:2
2.79 2.63 1.77
PI 18:0_20:2
5.17 3.37 2.03
PI 18:0_20:3
18.25 19.86 4.40
PI 18:0_20:4
20.81 28.55 10.61
PI 18:0_22:4
3.13 4.68 0.86
PI 18:0_22:5
3.80 5.74 1.26
PI 18:0_22:6
2.31 2.65 0.90
PI 18:1/18:1
5.52 4.31 12.07
PI 18:1_18:2
0.54 0.53 1.16
PI 18:1_20:1
0.91 0.50 1.55
PI 18:1_20:3
1.52 1.67 1.27
PI 18:1_20:4
2.03 2.59 3.42
PI 18:1_20:5
0.11 0.11 0.13
PI 18:1_22:4
0.27 0.45 0.26
PI 18:1_22:5
0.35 0.50 0.42
PI 18:1_22:6
0.17 0.22 0.25
PI 18:2_22:5
0.00 0.00 0.01

Factors:

F1Sample source:Breast cancer cell line | Genotype:control for Zeb1 stable knockdown
F2Sample source:Breast cancer cell line | Genotype:Wild-type
F3Sample source:Breast cancer cell line | Genotype:Zeb1 stable knockdown
  logo